Search - tctmd.com

Displaying 601 - 620 of 626

Sort: Relevancy | Date

Presentation TCT 2012

Synthesis of the New ESC LAA Closure Guidelines

Presenter: Peter Sick

October 23, 2012

Presentation TCT 2012

Quality-of-Life and Cost-Effectiveness After LAA Closure

Presenter: Vivek Reddy

October 23, 2012

Presentation TCT 2012

Lifetech LAA Closure Device: Description and Preclinical Results

Presenter: Yat-Yin Lam

October 23, 2012

Presentation TCT 2012

LAA Closure in Anticoagulation Contraindicated Patients: The ASAP Trial and Beyond

Presenter: Horst Sievert

October 23, 2012

Presentation TCT 2012

ICE Guidance for LAA Closure: Advantages and Limitations

Presenter: Vivek Reddy

October 23, 2012

Presentation TCT 2012

How to Become Trained and Start a LAA Closure Program

Presenter: Brian Whisenant

October 23, 2012

Presentation TCT 2012

Epicardial LAA Closure with the LARIAT (SentreHEART): Simple, Safe, and Effective?

Presenter: Mark Reisman

October 23, 2012

Presentation TCT 2012

Cardia LAA Closure Device: Description and Preclinical Results

Presenter: Juan Granada

October 23, 2012

Presentation TCT 2012

Attributes of the Perfect LAA Closure Device: What All the Companies Should Strive For

Presenter: Horst Sievert

October 23, 2012

Presentation TCT 2012

A Primer of LAA Closure Imaging: Essential Views and Pattern Recognition

Presenter: Rebecca Hahn

October 23, 2012

Presentation TCT 2012

Tips and Tricks in LAA Deployment

Presenter: William Gray

October 22, 2012

Presentation TCT 2012

Specialized Structural Interventions: Approaches to HOCM, Paravalvular Leak, Acute MI VSD, and LAA Closure

Presenter: Robert Sommer

October 22, 2012

Presentation TCT 2012

LAA Closure Devices

Presenter: Russell Brandwein

October 22, 2012

Presentation TCT 2012

Case 3: LAA Occlusion Case

Presenter: Alexander Osiev

October 22, 2012

Presentation TCT 2012

Thrombi on the Amplatzer Cardiac Plug after LAA Occlusion: Evaluation of Potential Echo Risk Factors

Presenter: Bj?rn Plicht, Philipp Kahlert, Hagen K?lsch, Thomas Buck, Raimund Erbel, Thomas F. Konorza

January 03, 2012

Presentation TCT 2012

New Generation Drug Eluting Stent Nobori: 2 Year Clinical Outcome of Patients with Chronic Total Occlusion.

Presenter: Bernard Chevalier, Dragan Sagic, Carlo Trani, Damras Tresukosol, Peep Laanmets, Mario Lombardi, Enrique Novo Garcia, Stefan Hoffmann, Harald Schwacke, Werner Jung, David Hildick-Smith, Gian Battista Danzi

January 03, 2012

Video

» Interview

The Value of FEops HEARTguide™ Computational Modeling in the Planning of Percutaneous LAA Closure - The PREDICT LAA Trial

September 17, 2022

Video

» Interview

SWISS-APERO: A Randomized Trial of the Amulet Versus Watchman FLX Devices for Left Atrial Appendage Closure

November 5, 2021

Video

Lifetech LAA Ocludder - LAmbre

May 11, 2018

Video

» Interview

AMULET IDE: One-Year Device Closure and Device-Related Thrombus Outcomes From a Randomized Trial of Amulet versus Watchman for Left Atrial Appendage Occlusion

November 5, 2021

Advertisement

Synthesis of the New ESC LAA Closure Guidelines

Quality-of-Life and Cost-Effectiveness After LAA Closure

Lifetech LAA Closure Device: Description and Preclinical Results

LAA Closure in Anticoagulation Contraindicated Patients: The ASAP Trial and Beyond

ICE Guidance for LAA Closure: Advantages and Limitations

How to Become Trained and Start a LAA Closure Program

Epicardial LAA Closure with the LARIAT (SentreHEART): Simple, Safe, and Effective?

Cardia LAA Closure Device: Description and Preclinical Results

Attributes of the Perfect LAA Closure Device: What All the Companies Should Strive For

A Primer of LAA Closure Imaging: Essential Views and Pattern Recognition

Tips and Tricks in LAA Deployment

Specialized Structural Interventions: Approaches to HOCM, Paravalvular Leak, Acute MI VSD, and LAA Closure

LAA Closure Devices

Case 3: LAA Occlusion Case

Thrombi on the Amplatzer Cardiac Plug after LAA Occlusion: Evaluation of Potential Echo Risk Factors

New Generation Drug Eluting Stent Nobori: 2 Year Clinical Outcome of Patients with Chronic Total Occlusion.

The Value of FEops HEARTguide™ Computational Modeling in the Planning of Percutaneous LAA Closure - The PREDICT LAA Trial

SWISS-APERO: A Randomized Trial of the Amulet Versus Watchman FLX Devices for Left Atrial Appendage Closure

Lifetech LAA Ocludder - LAmbre

AMULET IDE: One-Year Device Closure and Device-Related Thrombus Outcomes From a Randomized Trial of Amulet versus Watchman for Left Atrial Appendage Occlusion

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content